1. Home
  2. IRIX vs LRE Comparison

IRIX vs LRE Comparison

Compare IRIX & LRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IRIX
  • LRE
  • Stock Information
  • Founded
  • IRIX 1989
  • LRE 2001
  • Country
  • IRIX United States
  • LRE Japan
  • Employees
  • IRIX N/A
  • LRE N/A
  • Industry
  • IRIX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • LRE
  • Sector
  • IRIX Health Care
  • LRE
  • Exchange
  • IRIX Nasdaq
  • LRE Nasdaq
  • Market Cap
  • IRIX 16.5M
  • LRE 17.6M
  • IPO Year
  • IRIX 1996
  • LRE 2023
  • Fundamental
  • Price
  • IRIX $0.89
  • LRE $1.80
  • Analyst Decision
  • IRIX
  • LRE
  • Analyst Count
  • IRIX 0
  • LRE 0
  • Target Price
  • IRIX N/A
  • LRE N/A
  • AVG Volume (30 Days)
  • IRIX 70.7K
  • LRE 15.3K
  • Earning Date
  • IRIX 08-07-2025
  • LRE 01-01-0001
  • Dividend Yield
  • IRIX N/A
  • LRE N/A
  • EPS Growth
  • IRIX N/A
  • LRE N/A
  • EPS
  • IRIX N/A
  • LRE 0.29
  • Revenue
  • IRIX $48,804,000.00
  • LRE $117,804,154.00
  • Revenue This Year
  • IRIX $9.61
  • LRE N/A
  • Revenue Next Year
  • IRIX N/A
  • LRE N/A
  • P/E Ratio
  • IRIX N/A
  • LRE $6.19
  • Revenue Growth
  • IRIX N/A
  • LRE 8.82
  • 52 Week Low
  • IRIX $0.78
  • LRE $1.10
  • 52 Week High
  • IRIX $2.41
  • LRE $2.49
  • Technical
  • Relative Strength Index (RSI)
  • IRIX 36.71
  • LRE 54.60
  • Support Level
  • IRIX $0.87
  • LRE $1.64
  • Resistance Level
  • IRIX $1.00
  • LRE $2.11
  • Average True Range (ATR)
  • IRIX 0.04
  • LRE 0.14
  • MACD
  • IRIX -0.00
  • LRE -0.01
  • Stochastic Oscillator
  • IRIX 9.15
  • LRE 24.49

About IRIX IRIDEX Corporation

IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.

About LRE Lead Real Estate Co. Ltd

Lead Real Estate Co Ltd operates as a developer of luxury residential properties, including single-family homes and condominiums, across Tokyo, Kanagawa prefecture, and Sapporo. The company also operates hotels in Tokyo and leases apartment building units to individual customers in Japan and Dallas, Texas. Predominantly, its revenue is generated from developing and selling single-family homes and condominiums. The company's sole operating segment is real estate sales. Geographically, it derives revenue from Japan.

Share on Social Networks: